A comprehensive dosimetric study on switching from a Type-B to a Type-C dose algorithm for modern lung SBRT

[1] Siegel RL(2016)Cancer statistics, 2016 CA Cancer J Clin 66 7-30

[2] Miller KD(2001)Computed tomography-guided frameless stereotactic radiotherapy for stage I non-small cell lung cancer: A 5-year experience Int J Radiat Oncol Biol Phys 51 666-670

[3] Jemal A(2003)Extracranial stereotactic radioablation: Results of a phase I study in medically inoperable stage I non-small cell lung cancer Chest 124 1946-1955

[4] Uematsu M(2010)Stereotactic body radiation therapy for inoperable early stage lung cancer JAMA 303 1070-1076

[5] Shioda A(2016)Local tumor control probability modeling of primary and secondary lung tumors in stereotactic body radiotherapy Radiother Oncol 118 485-491

[6] Suda A(2014)Point/counterpoint. A 3D-conformal technique is better than IMRT or VMAT for lung SBRT Med Phys 41 040601-311

[7] Timmerman R(2011)Volumetric modulated arc planning for lung stereotactic body radiotherapy using conventional and unflattened photon beams: A dosimetric comparison with 3D technique Radiat Oncol 6 152-43

[8] Papiez L(2011)Dosimetric impact of interplay effect on RapidArc lung stereotactic treatment delivery Int J Radiat Oncol Biol Phys 79 305-418

[9] McGarry R(2012)Fast arc delivery for stereotactic body radiotherapy of vertebral and lung tumors Int J Radiat Oncol Biol Phys 83 e137-8179

[10] Timmerman R(2013)Experimentally studied dynamic dose interplay does not meaningfully affect target dose in VMAT SBRT lung treatments Med Phys 40 091710-4853

[1] Siegel RL(2016)Cancer statistics, 2016 CA Cancer J Clin 66 7-30

[2] Miller KD(2001)Computed tomography-guided frameless stereotactic radiotherapy for stage I non-small cell lung cancer: A 5-year experience Int J Radiat Oncol Biol Phys 51 666-670

[3] Jemal A(2003)Extracranial stereotactic radioablation: Results of a phase I study in medically inoperable stage I non-small cell lung cancer Chest 124 1946-1955

[4] Uematsu M(2010)Stereotactic body radiation therapy for inoperable early stage lung cancer JAMA 303 1070-1076

[5] Shioda A(2016)Local tumor control probability modeling of primary and secondary lung tumors in stereotactic body radiotherapy Radiother Oncol 118 485-491

[6] Suda A(2014)Point/counterpoint. A 3D-conformal technique is better than IMRT or VMAT for lung SBRT Med Phys 41 040601-311

[7] Timmerman R(2011)Volumetric modulated arc planning for lung stereotactic body radiotherapy using conventional and unflattened photon beams: A dosimetric comparison with 3D technique Radiat Oncol 6 152-43

[8] Papiez L(2011)Dosimetric impact of interplay effect on RapidArc lung stereotactic treatment delivery Int J Radiat Oncol Biol Phys 79 305-418

[9] McGarry R(2012)Fast arc delivery for stereotactic body radiotherapy of vertebral and lung tumors Int J Radiat Oncol Biol Phys 83 e137-8179

[10] Timmerman R(2013)Experimentally studied dynamic dose interplay does not meaningfully affect target dose in VMAT SBRT lung treatments Med Phys 40 091710-4853